智能慢病管理系统对接受PCI治疗的急性冠脉综合征患者预后的影响

目的探讨智能慢病管理系统对接受PCI治疗的急性冠脉综合征(ACS)患者预后的影响。方法采用便利抽样法,选择2016年2月-2017年5月在华中科技大学同济医学院附属协和医院就诊并接受救治的2212例ACS患者作为研究对象,采用随机数字表法分为两组,观察组1127例、对照组1085例。对照组给予常规护理,观察组给予常规护理及智能慢病管理系统的健康管理。比较两组患者治疗依从性、服药依从性、危险因素控制情况及不良心血管事件(MACE)发生情况。结果两组患者在主动调整生活方式、服药和定期复查依从性方面比较,差异有统计学意义(P<0.05)。两组患者在氯吡格雷、他汀类药物、血管紧张素转换酶抑制剂、硝酸酯类及β受体阻滞剂服药依从性方面比较,差异均有统计学意义(P<0.05)。两组患者在糖尿病、高血压和高脂血症控制方面比较,差异有统计学意义(P<0.05)。两组患者MACE发生率比较,差异有统计学意义(P<0.01)。结论智能慢病管理系统可提高ACS患者PCI术后治疗依从性、服药依从性,有效控制危险因素,改善患者预后。

Effects of mobile chronic disease management system on prognosis among acute coronary syndrome patients with PCI

Objective To explore the effects of mobile chronic disease management system on prognosis among acute coronary syndrome(ACS)patients with percutaneous coronary intervention(PCI).Methods From February 2016 to May 2017,this study selected 2212 ACS patients at Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology as subjects by convenience sampling.All of patients were divided into observation group(n=1127)and control group(n=1085)with the method of random number table.Control group carried out routine nursing,while observation group implemented routine nursing and health management with the mobile chronic disease management system.This study compared the treatment compliance,medication compliance,risk factors control and incidence of major adverse cardiovascular event(MACE)of patients between two groups.Results There were statistical differences in the active lifestyle modification,medication compliance and reexamine compliance of patients between two groups(P<0.05).There were also statistical differences in the compliance of clopidogrel,statins,angiotensin converting enzyme inhibitor,nitrates andβ-blocker,control of diabetes mellitus,hypertension and hyperlipidemia of patients between two groups(P<0.05).The incidence of MACE of patients between two groups was statistically different(P<0.01).Conclusions The mobile chronic disease management system can increase the treatment and medication compliance of ACS patients after PCI,effectively control risk factors and improve prognosis of patients.